AU Patent
AU2010202422B2 — Methods of treating children having hypoxic respiratory failure associated with clinical or echocardiographic evidence of pulmonary hypertension
Assigned to INO Therapeutics LLC · Expires 2010-10-21 · 16y expired
What this patent protects
Patent listed against Inomax.
Drugs covered by this patent
- Inomax (NITRIC OXIDE) · Vero Biotech Inc
Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.
Track this patent
Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.